Consistent efficacy outcomes between phase 2 and phase 3 trials  in Crohn’s disease or ulcerative colitis in adults: a meta-analysis

ConclusionsOur findings suggest that the main efficacy outcomes for CD and UC remain consistent between phase 2 and phase 3 trials, except for UC response rates. The efficacy data obtained from phase 2 trials can be considered reliable for the design of subsequent phase 3 trials.Registration: PROSPERO (CRD42023407947).
Source: Inflammation Research - Category: Research Source Type: research